PubMed1986
For fast neutron therapy and radiobiology beams, knowledge of the primary neutron spectrum is the most fundamental requirement for the definition of radiation quality. However, microdosimetric measurements in the form of single-event spectra not only complement the primary neutron spectrum as a statement of radiation quality but also provide a sensitive method of detecting changes in the radiation field in situations where it is no longer possible to have precise knowledge of the primary neutron spectrum, for example after collimator changes and in positions where the radiation field consists of a large scattered component. For the various collimator arrangements employed at the Gray Laboratory facility small perturbations of the radiation field are observed which can be related to a softening of the primary neutron spectrum with increasing field size of the collimator. Gamma fraction determinations are in very good agreement with measurements employing the dual chamber technique and also show small changes with collimator field size giving rise to gamma components ranging from 0.09 to 0.12, the higher values being measured for the larger field sizes. Quality changes represented by the shape of the measured event-size spectra and the derived microdosimetric parameters were greatest for off axis and phantom measurements. With increasing depth in water, yD was found to decrease from 47.3 keV micron-1 at 5 cm to 35.6 keV micron-1 at 15 cm depth, and the gamma fraction was found to increase from 0.23 to 0.40. Although there is no generally accepted and agreed method of relating microdosimetric information to biological effectiveness, the dual radiation theory in its original form (Kellerer and Rossi 1972) has been shown to be a very useful model for the assessment of the biological effectiveness of fast neutrons (Kellerer et al 1976). The microdosimetric parameter which is used in the dual radiation model is the dose mean specific energy corrected for saturation zeta* which, for a 2 micron simulated diameter, is related to the dose mean lineal energy corrected for saturation y* by zeta* = y* keV micron-1 X 0.51 X 10(-2) Gy. Values of y* determined for each of the collimator arrangements used at the Gray Laboratory show a spread of some 6% (table 1) and, as the dose fraction between lineal energies 5 and 150 keV micron-1 (the recoil proton component) do not alter by more than 3%, radiobiological experiments performed with different collimator arrangements would show no observable differences.(ABSTRACT TRUNCATED AT 400 WORDS)